Pure Global

A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis - Trial NCT06095115

Access comprehensive clinical trial information for NCT06095115 through Pure Global AI's free database. This Phase 3 trial is sponsored by Janssen Research & Development, LLC and is currently Recruiting. The study focuses on Plaque Psoriasis. Target enrollment is 600 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06095115
Phase 3
Recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06095115
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Retreatment

Study Focus

Plaque Psoriasis

JNJ-77242113

Interventional

drug

Sponsor & Location

Janssen Research & Development, LLC

Phoenix,Fort Smith,Fountain Valley,Fremont,Macon,Rolling Meadows,Plainfield,Owensboro,Lake Charles,Clarkston,New Brighton,Omaha,East Windsor,Athens,Boardman,Portland,Rapid City,Arlington,San Antonio,M, United States of America

Timeline & Enrollment

Phase 3

Oct 12, 2023

Jun 14, 2027

600 participants

Primary Outcome

Percentage of Participants Achieving an Investigator's Global Assessment (IGA) Score of 0 or 1 and Greater Than or Equal to (= )2-Grade Improvement From Baseline to Week 16,Percentage of Participants Achieving Psoriasis Area and Severity Index (PASI) 90 Response at Week 16

Summary

The purpose of this study is see how effective is JNJ-77242113 in participants with moderate
 to severe plaque psoriasis.

ICD-10 Classifications

Psoriasis
Large plaque parapsoriasis
Other psoriasis
Small plaque parapsoriasis
Arthropathic psoriasis

Data Source

ClinicalTrials.gov

NCT06095115

Non-Device Trial